Profile data is unavailable for this security.
About the company
SanBio Co Ltd is engaged in the regenerative cell business using allogeneic stem cells. The Company has the research and development base in the United States and conducts research, development, manufacture and sale of regenerative cell medicines in Japan. The Company aims to sell therapeutic agents for diseases with high unmet medical needs, mainly in diseases of the central nervous system. It is involved in the manufacture, development, non-clinical studies, clinical trials of technologies introduced from research institutes such as universities. The Company has five regenerative cell drugs, including the main product candidate SB623 (nerve regenerative cells), SB618 (function-enhancing type & Mesenchymal stem cells), SB308 (muscle stem cells), MSC1 (mesenchymal stem cells), and MSC2 (mesenchymal stem cells).
- Revenue in JPY (TTM)0.00
- Net income in JPY-2.64bn
- Incorporated2013
- Employees65.00
- LocationSanBio Co Ltd13F, St. Luke Tower, 8-1, Akashi-choCHUO-KU 104-0044JapanJPN
- Phone+81 362643481
- Websitehttps://www.sanbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Microwave Chemical Co Ltd | 1.89bn | 98.88m | 15.48bn | 59.00 | 222.66 | 9.06 | 87.90 | 8.18 | 4.45 | 4.45 | 116.78 | 109.32 | 0.6526 | 9.37 | 6.53 | 32,055,120.00 | 3.41 | -- | 4.65 | -- | 54.51 | -- | 5.23 | -- | 2.65 | 11.24 | 0.2309 | -- | 41.24 | -- | 168.39 | -- | -- | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.12bn | -3.61bn | 17.62bn | 208.00 | -- | 2.58 | -- | 2.88 | -73.48 | -73.48 | 129.22 | 134.92 | 0.433 | 2.13 | 3.24 | 29,423,080.00 | -25.54 | -- | -32.19 | -- | 42.11 | -- | -58.99 | -- | 2.54 | -- | 0.3256 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| Astena Holdings Co Ltd | 52.63bn | 1.62bn | 19.96bn | 1.40k | 11.88 | 0.6741 | 5.19 | 0.3793 | 40.98 | 40.98 | 1,332.61 | 722.46 | 0.8127 | 3.31 | 2.76 | 37,482,540.00 | 2.49 | 2.49 | 4.44 | 4.44 | 32.27 | 25.33 | 3.06 | 2.32 | 0.8713 | -- | 0.3517 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| Fuso Pharmaceutical Industries Ltd | 54.63bn | 1.34bn | 21.10bn | 1.31k | 14.42 | 0.5238 | 5.99 | 0.3863 | 154.89 | 154.89 | 6,295.26 | 4,263.41 | 0.725 | 3.31 | 2.20 | 41,572,300.00 | 1.78 | 1.79 | 2.95 | 2.87 | 25.29 | 27.78 | 2.45 | 2.59 | 1.09 | 65.13 | 0.2835 | 45.95 | 2.79 | 2.14 | 8.23 | 10.60 | -1.72 | -2.64 |
| Medical Data Vision Co Ltd | 6.42bn | 979.13m | 23.86bn | 262.00 | 23.26 | 5.35 | 22.58 | 3.72 | 25.63 | 25.63 | 168.05 | 111.30 | 1.15 | 140.01 | 6.11 | 24,500,100.00 | 17.17 | 16.16 | 24.01 | 20.88 | 78.38 | 81.90 | 14.87 | 15.52 | 2.58 | 24.66 | 0.00 | 19.98 | 5.15 | 12.40 | 12.48 | 69.75 | -23.95 | -- |
| Pharma Foods International Co., Ltd. | 65.08bn | 4.76bn | 24.40bn | 670.00 | 5.08 | 2.56 | 4.54 | 0.3749 | 165.17 | 165.17 | 2,257.80 | 327.80 | 1.84 | 2.22 | 12.71 | 97,135,820.00 | 13.44 | 8.40 | 48.12 | 19.20 | 79.89 | 81.34 | 7.32 | 3.85 | 0.8449 | 91.33 | 0.6839 | 28.26 | 13.94 | 53.90 | 923.80 | 57.92 | 51.63 | -- |
| StemRIM Inc | 2.35bn | 179.40m | 26.99bn | 44.00 | 128.24 | 2.75 | -- | 11.48 | -0.1097 | -0.1097 | 37.43 | 159.71 | 0.2453 | -- | -- | 53,409,090.00 | 1.87 | -6.71 | 1.89 | -6.83 | -- | -- | 7.63 | -45.80 | 78.90 | 652.72 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
| Cuorips Inc | 39.89m | -598.68m | 27.33bn | 46.00 | -- | 4.52 | -- | 685.11 | -76.49 | -76.49 | 5.13 | 766.30 | 0.0081 | 3.93 | 39.73 | 867,130.40 | -12.10 | -- | -12.39 | -- | 45.79 | -- | -1,500.91 | -- | 35.89 | -- | 0.00 | -- | 175.12 | -- | -20.45 | -- | -- | -- |
| SanBio Co Ltd | 0.00 | -2.64bn | 29.65bn | 65.00 | -- | 10.51 | -- | -- | -40.50 | -40.50 | 0.00 | 41.11 | 0.00 | -- | -- | -- | -43.74 | -42.00 | -52.38 | -48.88 | -- | -- | -- | -4,790.72 | -- | -- | 0.1923 | -- | -- | -- | 52.44 | -- | 53.94 | -- |
| Mizuho Medy Co Ltd | 10.99bn | 3.77bn | 31.15bn | 180.00 | 8.25 | 1.99 | 7.85 | 2.83 | 396.27 | 396.27 | 1,153.85 | 1,645.86 | 0.5776 | 2.04 | 2.04 | 61,054,080.00 | 19.84 | 31.46 | 23.70 | 39.78 | 73.47 | 74.85 | 34.34 | 33.64 | 6.45 | -- | 0.00 | 34.83 | -37.49 | 11.34 | -51.85 | 32.64 | -17.74 | 32.85 |
| Koa Shoji Holdings Co Ltd | 22.27bn | 2.86bn | 32.96bn | 297.00 | 11.54 | 1.50 | 9.26 | 1.48 | 72.09 | 72.09 | 562.08 | 554.93 | 0.7777 | 5.99 | 2.42 | 74,979,020.00 | 9.97 | 7.91 | 12.38 | 9.93 | 30.12 | 28.74 | 12.83 | 10.48 | 3.69 | 29.24 | 0.1197 | 19.64 | 8.35 | 8.27 | 13.90 | 29.60 | -21.26 | 15.52 |
| Fuji Pharma Co Ltd | 41.64bn | 5.06bn | 38.42bn | 1.62k | 7.45 | 0.8988 | 4.67 | 0.9226 | 208.19 | 208.19 | 1,713.27 | 1,726.70 | 0.5039 | 1.40 | 2.82 | 25,687,230.00 | 6.12 | 4.10 | 8.90 | 5.58 | 38.51 | 42.41 | 12.15 | 7.55 | 0.7165 | -- | 0.3947 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Daito Pharmaceutical Co Ltd | 45.19bn | 3.28bn | 39.07bn | 1.01k | 11.98 | 0.7516 | 5.75 | 0.8646 | 207.85 | 207.85 | 2,864.81 | 3,311.81 | 0.6193 | 1.81 | 2.65 | 44,701,280.00 | 4.35 | 6.99 | 5.64 | 9.29 | 21.38 | 22.71 | 7.03 | 8.83 | 1.15 | -- | 0.1231 | 17.08 | 3.77 | 2.49 | -22.88 | 3.43 | 7.48 | 12.70 |
| Seikagaku Corp | 34.68bn | 1.31bn | 42.33bn | 976.00 | 31.04 | 0.5668 | 14.63 | 1.22 | 24.00 | 24.00 | 635.69 | 1,314.47 | 0.4431 | 1.75 | 4.31 | 35,530,740.00 | 1.67 | 0.438 | 1.80 | 0.4797 | 50.52 | 55.91 | 3.77 | 1.07 | 5.44 | -- | 0.0055 | 452.20 | -4.00 | 2.09 | -40.10 | -10.63 | 8.40 | 0.00 |
Data as of Apr 19 2024. Currency figures normalised to SanBio Co Ltd's reporting currency: Japanese Yen JPY
3.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.19m | 1.73% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 544.30k | 0.79% |
| Simplex Asset Management Co., Ltd.as of 04 Apr 2024 | 226.10k | 0.33% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 211.30k | 0.31% |
| BlackRock Advisors (UK) Ltd.as of 02 Apr 2024 | 60.90k | 0.09% |
| Nomura Asset Management Co., Ltd.as of 30 Nov 2022 | 59.00k | 0.09% |
| TIAA-CREF Investment Management LLCas of 29 Feb 2024 | 36.82k | 0.05% |
| The Vanguard Group, Inc.as of 29 Feb 2024 | 20.70k | 0.03% |
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 20.09k | 0.03% |
| KLP Kapitalforvaltning ASas of 29 Feb 2024 | 19.60k | 0.03% |
More ▼
Data from 31 Dec 2023 - 11 Apr 2024Source: FactSet Research Systems Inc.
